P.350Onasemnogene abeparvovec gene-replacement therapy (GRT) in pre-symptomatic spinal muscular atrophy (SMA)

Autor: Schultz, M., Swoboda, K., Farrar, M., McMillan, H., Parsons, J., Kernbauer, E., Farrow, M., Ogrinc, F., Kavanagh, S., Feltner, D., McGill, B., Spector, S., L'Italien, J., Sproule, D., Strauss, K.
Zdroj: In Neuromuscular Disorders October 2019 29 Supplement 1:S183-S183
Databáze: ScienceDirect